72.00EUR+2.13%Mkt Cap: —P/E: 13.552d ago
Vetoquinol SA, a veterinary pharmaceutical company, engages in designing, developing, and selling of veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Paci…
Industry Peers
Healthcare$1.14TUSDP/E 43.0
$658.89BUSDP/E 31.7
$462.68BUSDP/E 74.0
$375.50BUSDP/E 122.7
$341.92BUSDP/E 24.5
$348.81BUSDP/E 25.0
$279.13BUSDP/E 22.3
$274.07BUSDP/E 23.6
$240.45BUSDP/E 24.5
$231.49BUSDP/E 24.5
$238.75BUSDP/E 27.4
$226.85BUSDP/E 33.1
$190.75BUSDP/E 11.3
$198.81BUSDP/E 36.9
$183.02BUSD
$160.96BUSDP/E 37.2
$151.78BUSDP/E 38.6
$142.49BUSDP/E 45.6
$139.84BUSDP/E 32.2
$138.11BUSDP/E 14.9
Key Statistics
Company
Market Cap—
Enterprise Value667.00M $
Revenue (TTM)571.40M $
Gross Profit334.73M $
Net Income (TTM)62.35M $
Revenue/Share49.17 USD
Last Price72.00 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees2.4K
CountryGB
SectorHealthcare
Industry—
ISINFR0004186856
Valuation
P/E (Trailing)13.55
P/E (Forward)—
PEG—
EV/EBITDA5.93
EV/Revenue1.17
P/S—
P/B1.39
EPS (TTM)5.32
EPS (Forward)—
52W Range
70.50100% of range72.00
52W High72.00 EUR
52W Low70.50 EUR
Profitability
Gross Margin58.58%
Oper. Margin16.82%
EBITDA Margin19.68%
Profit Margin10.91%
ROE9.82%
ROA6.62%
Growth
Revenue Growth-2.40%
Earnings Growth-5.10%
Cash Flow & Leverage
Operating CF78.34M $
CapEx (TTM)—
FCF Margin9.26%
FCF Yield—
Net Debt-223.68M $
Net Debt/EBITDA-1.99
Balance Sheet
Debt/Equity2.59
Current Ratio3.08
Quick Ratio2.21
Book Value/Sh50.88 EUR
Cash/Share19.02 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.9300 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.11.86M
Float3.65M
Insiders67.01%
Institutions12.67%
Technical
SMA 50102.37 (-29.7%)
SMA 20091.66 (-21.5%)
Beta0.88
S&P 52W Chg20.80%
Avg Vol (30d)10
Avg Vol (10d)76
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—